Plus Therapeutics
Price & Volume
Stats
See more52W Range | $0.92-$2.67 |
Market Cap | $7M |
Shares Short | 88,408 |
Financials
See moreRevenue (12 Mos) | $5.7M |
Revenue Growth (YoY) | 17.4% |
Gross Profit (12 Mos) | -$5.4M |
Diluted EPS | -$2.37 |
News
See moreYahoo Finance • 5 days ago
Plus Therapeutics Secures $5.7 Million Financing to Support Leptomeningeal Metastases Program
Yahoo Finance • last year
Plus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar
About
CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
CFO | Mr. Andrew J. Sims CPA |
Address | 4200 Marathon Boulevard, Austin, TX, United States, 78756 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
